Genomic analysis of Neisseria meningitidis carriage isolates during an outbreak of serogroup C clonal complex 11, Tuscany, Italy.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
25
01
2019
accepted:
13
05
2019
entrez:
29
5
2019
pubmed:
29
5
2019
medline:
29
1
2020
Statut:
epublish
Résumé
In 2015-2016, a cross-sectional carriage survey was performed in Tuscany Region, Italy, during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C clonal complex 11 (MenC:cc11). This study aims to evaluate the genomic profile of meningococcal carriage isolates collected during the survey. Whole-genome sequencing (WGS) was performed using Illumina MiSeq on 85 cultivated meningococcal carriage isolates received at the Dept. of Infectious Disease, National Institute of Health (Istituto Superiore di Sanità, ISS), as National Reference Laboratory (NRL) for Invasive Meningococcal Disease (IMD). De novo assembled genomes were scanned by the BIGSdb platform to assign: the genotypic profiles, the cgMLST, the vaccine antigen variants and allele types of antimicrobial resistance associated genes, together with denitrification pathway loci. Capsule null and non-groupable meningococci accounted for 52.9% and 10.6%, respectively. Among the remaining carriage isolates, serogroup B was the predominant (71.0%). Serogroup C meningococci were culture negative and unavailable for WGS. Overall, 64 genotypic profiles were identified and, based on cgMLST, isolates clustered according to clonal complexes. Eight isolates (9.4%) harbored at least one gene encoding a 4CMenB vaccine antigen. Mutated penA alleles were found in more than 82%. Finally, complete aniA and norB coding sequences were detected among 71.8% of carriage isolates. Meningococcal carriage isolates collected during the MenC:cc11 outbreak were characterized by an extensive genetic diversity. The lack of outbreak-related isolates among carriage might be attributable to the high transmissibility with low duration of colonization of MenC:cc11 meningococci.
Sections du résumé
BACKGROUND
In 2015-2016, a cross-sectional carriage survey was performed in Tuscany Region, Italy, during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C clonal complex 11 (MenC:cc11). This study aims to evaluate the genomic profile of meningococcal carriage isolates collected during the survey.
METHODS
Whole-genome sequencing (WGS) was performed using Illumina MiSeq on 85 cultivated meningococcal carriage isolates received at the Dept. of Infectious Disease, National Institute of Health (Istituto Superiore di Sanità, ISS), as National Reference Laboratory (NRL) for Invasive Meningococcal Disease (IMD). De novo assembled genomes were scanned by the BIGSdb platform to assign: the genotypic profiles, the cgMLST, the vaccine antigen variants and allele types of antimicrobial resistance associated genes, together with denitrification pathway loci.
RESULTS
Capsule null and non-groupable meningococci accounted for 52.9% and 10.6%, respectively. Among the remaining carriage isolates, serogroup B was the predominant (71.0%). Serogroup C meningococci were culture negative and unavailable for WGS. Overall, 64 genotypic profiles were identified and, based on cgMLST, isolates clustered according to clonal complexes. Eight isolates (9.4%) harbored at least one gene encoding a 4CMenB vaccine antigen. Mutated penA alleles were found in more than 82%. Finally, complete aniA and norB coding sequences were detected among 71.8% of carriage isolates.
CONCLUSIONS
Meningococcal carriage isolates collected during the MenC:cc11 outbreak were characterized by an extensive genetic diversity. The lack of outbreak-related isolates among carriage might be attributable to the high transmissibility with low duration of colonization of MenC:cc11 meningococci.
Identifiants
pubmed: 31136624
doi: 10.1371/journal.pone.0217500
pii: PONE-D-19-02402
pmc: PMC6538176
doi:
Substances chimiques
Bacterial Proteins
0
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0217500Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Open Forum Infect Dis. 2015 Aug 13;2(3):ofv117
pubmed: 26357666
Mol Biol Evol. 2006 Feb;23(2):254-67
pubmed: 16221896
Emerg Infect Dis. 2011 Sep;17(9):1762-3
pubmed: 21888817
Euro Surveill. 2015;20(45):
pubmed: 26606870
PLoS One. 2016 May 11;11(5):e0154047
pubmed: 27167067
FEMS Microbiol Rev. 2007 Jan;31(1):52-63
pubmed: 17233635
BMC Infect Dis. 2019 Jan 8;19(1):29
pubmed: 30621624
Euro Surveill. 2015 Jan 22;20(3):
pubmed: 25635319
Antimicrob Agents Chemother. 2007 Aug;51(8):2784-92
pubmed: 17517841
IUBMB Life. 2008 Sep;60(9):629-36
pubmed: 18618739
Nat Rev Microbiol. 2013 Oct;11(10):728-36
pubmed: 23979428
Vaccine. 2019 Feb 8;37(7):991-1000
pubmed: 30661831
Infect Genet Evol. 2008 Sep;8(5):558-65
pubmed: 18479979
J Infect. 2016 Aug;73(2):136-44
pubmed: 27235364
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4237-4242
pubmed: 28373547
Microbiology. 2009 Dec;155(Pt 12):4093-4103
pubmed: 19762442
Emerg Infect Dis. 2012 Jan;18(1):63-70
pubmed: 22261040
J Infect Dis. 2016 Jun 1;213(11):1777-85
pubmed: 26747709
Euro Surveill. 2012 Dec 13;17(50):
pubmed: 23241233
Euro Surveill. 2018 Aug;23(34):
pubmed: 30153883
J Clin Microbiol. 2016 Jan;54(1):25-34
pubmed: 26311858
Euro Surveill. 2009 Apr 23;14(16):
pubmed: 19389338
Hum Vaccin Immunother. 2012 May;8(5):685-8
pubmed: 22508411
PLoS One. 2015 Oct 07;10(10):e0139376
pubmed: 26445461
PLoS One. 2017 Sep 20;12(9):e0185038
pubmed: 28931058
Lancet Infect Dis. 2010 Dec;10(12):853-61
pubmed: 21075057
Vaccine. 2009 Jun 24;27 Suppl 2:B64-70
pubmed: 19464092
BMC Genomics. 2014 Dec 18;15:1138
pubmed: 25523208
Int J Med Microbiol. 2004 Sep;294(2-3):75-82
pubmed: 15493817
Antimicrob Agents Chemother. 2018 Aug 27;62(9):
pubmed: 29914967
J Clin Microbiol. 2015 Jul;53(7):2154-62
pubmed: 25926489
MMWR Morb Mortal Wkly Rep. 2016 Jun 03;65(21):550-2
pubmed: 27254649
Lancet Infect Dis. 2013 May;13(5):416-25
pubmed: 23414709
Euro Surveill. 2016;21(12):
pubmed: 27035155
J Clin Microbiol. 2014 Jun;52(6):1901-10
pubmed: 24648565
Clin Microbiol Infect. 2014 May;20(5):391-5
pubmed: 24766477
Clin Microbiol Infect. 2017 Aug;23(8):573.e1-573.e7
pubmed: 28192234
Clin Infect Dis. 2003 Nov 1;37(9):1183-8
pubmed: 14557962
Euro Surveill. 2013 Jul 11;18(28):
pubmed: 23870095
Emerg Infect Dis. 2017 Feb;23(2):336-339
pubmed: 28098538